Wu C, Fortier KJ, LaPensee K, Fan W, Mitchell M, Cyr PL , Jensen IS . A US hospital economic impact model for oritavancin in ABSSSI patients with risk of MRSA infections. Abstract PSS10 , ISPOR 17th Annual European Congress 2014.
View Abstract
Publication: Abstracts and Presentations
/ Topics: Health Economics and Outcomes Research (HEOR)
Erichsen R, Kelsh MA , Oliner KS, Nielsen KB, Frøslev T, Lænkholm AV, et al. Prognostic impact of tumor MET expression among patients with stage IV gastric cancer: A Danish cohort study. Presented at International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE), Taipei, Taiwan, October 28–30, 2014.
Publication: Abstracts and Presentations
/ Topics: Cancer
Jensen IS , Bay C, Cyr PL . Estimating the impact of combining cangrelor and bivalirudin to a U.S. hospital performing PCI procedures. ISPOR 18th Annual International Meeting, New Montreal Quebec, 2014.
Publication: Abstracts and Presentations
/ Topics: Health Economics and Outcomes Research (HEOR)
Jensen IS , Wu C, Bay CB, Cyr PL . Estimating the clinical value of cangrelor in patients undergoing PCI. International Academy of Cardiology, 19th World Congress on Heart Disease, Boston, MA, 2014.
Publication: Abstracts and Presentations
/ Topics: Health Economics and Outcomes Research (HEOR)
Wu C, Fortier K, Fan WJ, LePensse K, Bay CB, Cyr PL , Jensen IS . A U.S. hospital budget impact model for oritivancin in ABSSSI patients with risk of MRSA infections. ISPOR 16th Annual European Congress, Amsterdam, Netherlands, 2014.
Publication: Abstracts and Presentations
/ Topics: Health Economics and Outcomes Research (HEOR)
Bay C, Cyr PL , Jensen IS . Estimating the value of cangrelor from eliminating preloading in coronary artery bypass graft (CABG) patients. ISPOR 16th Annual European Congress, Amsterdam, Netherlands, 2014.
Publication: Abstracts and Presentations
/ Topics: Health Economics and Outcomes Research (HEOR)
Pinto DS, Nicholson G, Harrington RA, Cyr PL , Bhatt DL. CHAMPION PHOENIX Study economic results: Direct hospitalization costs of patients receiving clopidogrel or cangralor during percutaneous coronary intervention. American Heart Association QCOR conference, Baltimore, MD, 2014.